MARKET

TELO

TELO

Telomir Pharms
NASDAQ
1.230
+0.020
+1.65%
After Hours: 1.230 0 0.00% 17:15 09/25 EDT
OPEN
1.220
PREV CLOSE
1.210
HIGH
1.230
LOW
1.200
VOLUME
55.97K
TURNOVER
--
52 WEEK HIGH
2.091
52 WEEK LOW
0.8885
MARKET CAP
84.59M
P/E (TTM)
-1.3508
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TELO last week (0914-0918)?
Weekly Report · 09/21 09:13
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/18 21:06
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 09/17 21:06
Telomir Publishes Data Validating Telomir-Zn For AMD Alongside Cancer Indications; Stock Up
NASDAQ · 09/17 15:31
Telomir Pharmaceuticals Price Target Announced at $4.00/Share by Maxim Group
Dow Jones · 09/17 15:21
Telomir Pharmaceuticals publishes new preclinical research on Telomir-Zn
TipRanks · 09/17 13:25
Telomir-Zn Preclinical Data Highlight Retinal Regeneration Potential
TipRanks · 09/17 12:58
Telomir Pharmaceuticals initiated with a Buy at Maxim
TipRanks · 09/17 11:55
More
About TELO
Telomir Pharmaceuticals, Inc. is a biotechnology company developing small-molecule therapeutics designed to target epigenetic and metabolic mechanisms implicated in cancer, aging, and degenerative disease. The Company's lead candidate, Telomir-1 (Telomir-Zn), is an investigational therapy that has demonstrated activity in preclinical studies involving modulation of intracellular metal homeostasis, epigenetic regulation, mitochondrial function, and genomic stability. Telomir-1 is an oral small molecule metal ion regulator designed to extend telomere caps, maintain cellular balance, and combat oxidative stress, a key driver of aging and disease progression. By modulating essential metal ions such as iron, and copper, Telomir-1 may help protect against age related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease, and Age-related Macular Degeneration (AMD), as well as Type 2 diabetes, breast cancer, and Alzheimer’s disease.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.